Social, clinical and microbiological differential characteristics of tuberculosis among immigrants in Spain
- PMID: 21283716
- PMCID: PMC3024422
- DOI: 10.1371/journal.pone.0016272
Social, clinical and microbiological differential characteristics of tuberculosis among immigrants in Spain
Abstract
Background: To identify the differential tuberculosis (TB) characteristics within the immigrant population with respect to natives in Spain.
Methodology/principal findings: A prospective cohort study design was implemented to examine the TB cases diagnosed and starting standard antituberculous treatment in Spain, between January 1st 2006 and March 31st 2007. A logistic regression analysis was performed to determine differential characteristics. 1,490 patients were included in the study population, 1,048 natives and 442 (29.7%) immigrants. According to the multivariate analysis, the following variables were significantly associated with immigrant TB cases: younger age (OR = 3.79; CI:2.16-6.62), living in group situation (OR = 7.61; CI:3.38-12.12), lower frequency of disabled (OR:0.08; CI:0.02-0.26) and retired (OR:0.21; CI:0.09-0.48) employment status, lower frequency of pulmonary disease presentation (OR = 0.47; CI:0.24-0.92), primary or emergency care admission (OR = 1.80; CI:1.05-3.06 and OR = 2.16; CI:1.36-3.45), drug resistance (OR = 1.86; CI:1.01-3.46), treatment default (OR:2.12; CI:1.18-3.81), lower frequency of alcohol and cigarette consumption (OR = 2.10; CI:1.42-3.11 and OR = 2.85; CI:2.10-3.87 respectively), more directly observed treatment (OR = 1.68; CI:1.04-2.69), and poor understanding of TB disease and its treatment (OR = 3.11; CI:1.86-5.20). The low percentage of primary MDR-TB in the native population (0.1% vs. 2.2% of immigrants) should be noted.
Conclusions/significance: The differences show the need to introduce specific strategies in the management of TB within the immigrant population, including the improvement of social and work conditions.
Conflict of interest statement
References
-
- WHO Report. World Health Organization. WHO/HTM/TB/2008.393; 2008. Global Tuberculosis Control 2008. Surveillance, planning, financing. .
-
- Maher D, Raviglione M. Global epidemiology of tuberculosis. Clin Chest Med. 2005;26:167–82. - PubMed
-
- Wright A, Zignol M, Van Deun A, Falzon D, Ruesch Gerdes S, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009;373:1861–73. - PubMed
-
- World Health Organization. lMultidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. 2010.
-
- Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis. 2010;14:382–90. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
